Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - ACCOUNTS PAYABLE
Accounts Payable IKT - Inhibikase Therapeutics, Inc.
647 K
LAST VALUE
-22.96%
2 YEAR CAGR
-7.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR